While the US and EU have struck a deal on tariffs that seems to be holding, a dark cloud remains over the future of pharma in Ireland. Despite assertions from the European Commission that the deal would bring clarity and certainty to pharma exporters, confusion reigns.
All to discuss with Brendan Murphy, Tax Partner at Baker Tilly Ireland.
